One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Enduring Economic Effects of a Cancer Diagnosis in Adolescence and Young Adulthood.
doi : 10.1200/JCO-25-01005
Volume 43(22) pgs. 2453-2553 August 1, 2025
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.
doi : 10.1200/JCO-24-02683
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
doi : 10.1200/JCO-25-00183
Long-Term Dynamic Financial Impacts Among Adolescents and Young Adults With Cancer: A Longitudinal Matched-Cohort Study.
doi : 10.1200/JCO-24-02121
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma.
doi : 10.1200/JCO-24-02348
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab +/- Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
doi : 10.1200/JCO-24-02612
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.
doi : 10.1200/JCO-25-00748
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
doi : 10.1200/JCO-25-00678
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.
doi : 10.1200/JCO-25-00744
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
doi : 10.1200/JCO-25-00166
Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?.
doi : 10.1200/JCO-25-00150
Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?.
doi : 10.1200/JCO-25-00420
Erratum: Fertility Preservation in People With Cancer: ASCO Guideline Update.
doi : 10.1200/JCO-25-01373
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
doi : 10.1200/JCO-25-01367
